Is mechanical dyssynchrony a therapeutic target in heart failure with preserved ejection fraction?

被引:16
|
作者
Menet, Aymeric [1 ]
Greffe, Lorraine [1 ]
Ennezat, Pierre-Vladimir [2 ]
Delelis, Francois [1 ]
Guyomar, Yves [1 ]
Castel, Anne Laure [1 ]
Guiot, Aurelie [1 ]
Graux, Pierre [1 ]
Tribouilloy, Christophe [3 ,4 ]
Marechaux, Sylvestre [1 ,4 ]
机构
[1] Univ Lille Nord France, GCS Groupement Hop, Inst Catholique Lille, Fac Libre Med,Univ Catholique Lille, Lille, France
[2] CHU Grenoble, Grenoble, France
[3] CHU Amiens, Pole Cardiovasc & Thorac, Amiens, France
[4] Univ Picardie, INSERM, U1088, Amiens, France
关键词
CARDIAC-RESYNCHRONIZATION THERAPY; LEFT-VENTRICULAR DYSSYNCHRONY; BUNDLE-BRANCH BLOCK; EUROPEAN-SOCIETY; TASK-FORCE; COLLABORATION; PREVALENCE; GUIDELINES; ASYNCHRONY; SURVIVAL;
D O I
10.1016/j.ahj.2014.08.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Previous studies have found a high frequency of mechanical dyssynchrony in patients with heart failure (HF) with preserved ejection fraction (HFpEF), hence suggesting that cardiac resynchronization therapy (CRT) may be considered in HFpEF. The present study was designed to compare the amount of mechanical dyssynchrony between HFpEF patients and (1) HF with reduced EF (HFrEF) patients with an indication for CRT (HFrEF-CRT(+)) group, (2) HFrEF patients with QRS duration <120 ms (HFrEF-QRS <120 ms) group, and (3) hypertensive controls (HTN). Methods Electrical (ECG) and mechanical dyssynchrony (atrio-ventricular dyssynchrony, interventricular dyssynchrony, intraventricular dyssynchrony) were assessed using conventional, tissue Doppler, and Speckle Tracking strain echocardiography in 40 HFpEF patients, 40 age-and sex-matched HTN controls, 40 HFrEF-QRS <120 ms patients, and 40 HFrEF-CRT(+) patients. Results The frequency of left bundle branch block was low in HFpEF patients (5%) and similar to HTN controls (5%, P = 0.85). Indices of dyssynchrony were similar between HFpEF and HTN patients or HFrEF-QRS <120 ms patients. In contrast, most indices of dyssynchrony differed between HFpEF and HFrEF-CRT(+) patients. The principal components analysis on the entire cohort of 160 patients yielded 2 homogeneous groups of patients in terms of dyssynchrony, the first comprising HFrEF-CRT(+) patients and the second comprising HTN, HFrEF-QRS <120 ms and HFpEF patients. Conclusions Mechanical dyssynchrony in HFpEF does not differ from that of patients with HTN or patients with HFrEF and a narrow QRS. This data raises concerns regarding the role of dyssynchrony in the pathophysiology of HFpEF and thereby the potential usage of CRT in HFpEF.
引用
收藏
页码:909 / +
页数:9
相关论文
共 50 条
  • [1] Mechanical dyssynchrony in heart failure with preserved ejection fraction: a treatment target or a dead end?
    Popescu, Bogdan A.
    Beladan, Carmen C.
    Popescu, Andreea C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (08) : 1053 - 1055
  • [2] Inflammation as a therapeutic target in heart failure with preserved ejection fraction
    Peh, Zhen Hui
    Dihoum, Adel
    Hutton, Dana
    Arthur, J. Simon C.
    Rena, Graham
    Khan, Faisel
    Lang, Chim C. C.
    Mordi, Ify R.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [3] Prognostic importance of left ventricular mechanical dyssynchrony in heart failure with preserved ejection fraction
    Biering-Sorensen, Tor
    Shah, Sanjiv J.
    Anand, Inder
    Sweitzer, Nancy
    Claggett, Brian
    Liu, Li
    Pitt, Bertram
    Pfeffer, Marc A.
    Solomon, Scott D.
    Shah, Amil M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (08) : 1043 - 1052
  • [4] PROGNOSTIC IMPORTANCE OF LEFT VENTRICULAR MECHANICAL DYSSYNCHRONY IN HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Biering-Sorensen, Tor
    Shah, Sanjiv
    Ananda, Inderjit
    Sweitzer, Nancy
    Claggett, Brian
    Pitt, Bertram
    Pfeffer, Marc
    Solomon, Scott
    Shah, Amil
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1484 - 1484
  • [5] Impact of hypoalbuminemia in heart failure with preserved ejection fraction: a future therapeutic target?
    Maria Ines Pires, M. I.
    Goncalves, L.
    Antunes, H.
    Gil, J.
    Abreu, L.
    Almeida, I.
    Costa Cabral, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 230 - 230
  • [6] Epoxyeicosatrienoic acid: A potential therapeutic target of heart failure with preserved ejection fraction
    Zhang, Min
    Shu, Hongyang
    Chen, Chen
    He, Zuowen
    Zhou, Zhou
    Wang, Dao Wen
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 153
  • [7] Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction A Modifiable Therapeutic Target?
    Berry, Colin
    Sykes, Robert
    JACC-CARDIOVASCULAR IMAGING, 2022, 15 (06) : 1012 - 1014
  • [8] Left Ventricular Stiffening as Therapeutic Target for Heart Failure With Preserved Ejection Fraction
    Sakata, Yasushi
    Ohtani, Tomohito
    Takeda, Yasuharu
    Yamamoto, Kazuhiro
    Mano, Toshiaki
    CIRCULATION JOURNAL, 2013, 77 (04) : 886 - 892
  • [9] The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction
    Greene, Stephen J.
    Gheorghiade, Mihai
    Borlaug, Barry A.
    Pieske, Burkert
    Vaduganathan, Muthiah
    Burnett, John C., Jr.
    Roessig, Lothar
    Stasch, Johannes-Peter
    Solomon, Scott D.
    Paulus, Walter J.
    Butler, Javed
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (06):
  • [10] LV Mechanical Dyssynchrony in Heart Failure With Preserved Ejection Fraction Complicating Acute Coronary Syndrome
    Lee, Alex Pui-Wai
    Zhang, Qing
    Yip, Gabriel
    Fang, Fang
    Liang, Yu-Jia
    Xie, Jun-Min
    Lam, Yat-Yin
    Yu, Cheuk-Man
    JACC-CARDIOVASCULAR IMAGING, 2011, 4 (04) : 348 - 357